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A commentary on
The interleukin-2 T cell system: a new cell growth model
by Cantrell DA, Smith KA. Science (1984) 224:1312–16. doi: 10.1126/science.6427923
Having created unique and novel cellular and molecular reagents, we could approach questions
that had perplexed investigators interested in cell growth for over 50 years, i.e., the basis for
variable cell cycle transit times of individual cells among genetically homogeneous cell populations
(1). Studies of all cell populations, both prokaryote and eukaryote, revealed that within a cell
population, the cell cycle times of individual cells follow a normal distribution when examined as
a function of the division rate (the rate-normal distribution). Thus, some cells proliferate slowly
while others proliferate faster, with most cells distributed about the mean on a log-linear plot. Prior
to the discovery of the IL-2 molecule (2) and IL-2 receptors (IL-2R) (3), T cell populations were
known to follow this rate-normal distribution, common to all living cells. Mathematical analysis of
proliferating cell populations indicated that individual cell variability in cell cycle transit times was
stochastic, depending upon a “hidden variable.” However, once the “hidden” molecular variables
of T cell cycle proliferation had been identified (the IL-2 concentration, IL-2R density, affinity of
the IL-2/IL-2R interaction, and the duration of the IL-2/IL-2R interaction), experiments could be
preformed for the first time revealing that as long as these crucial characteristics of T cell cycle
progression were known, then the variability of cell cycle transit times were entirely predictable and
deterministic, not probabilistic or left to chance.
These experiments and approaches were possible because of painstaking attention to the creation
of critical cell clones and homogeneous purified IL-2 molecules, as well as the development of
the radiolabeled IL-2 binding assay, and monoclonal antibodies reactive with both IL-2 and its
receptor. Moreover, the employment of the flow cytometer allowed us to proceed beyond studies
of cell populations to quantify the intermolecular interactions of individual cells for the first time.
Doreen Cantrell, a postdoctoral fellow skilled in flow cytometry, was critical to our experimental
approach. Because the growth characteristics of all known cell populations are identical to those of
T cell populations, it followed that individual cells of all other cell populations would demonstrate
the same type of molecular determinants. Thus, the title of this article: “The interleukin-2 T cell
system: A new cell growth model,” a new universal paradigm in cell and molecular biology (1).
The significance of these findings was obvious. As cells of all tissues, especially of metazoans, have
identical growth characteristics of T cells, it followed that the cells of all metazoans are regulated
in the same molecular fashion, i.e., cells are directed to undergo all-or-none (quantal) cell fate
decisions by critical molecular concentrations. Furthermore, as all malignant cells arise from a
single cell, so that all malignancies are clonal in origin, a gain of function mutation of one of
the genes encoding the molecular determinants of cell cycle progression could obviate the strict
cytokine/receptor/signaling pathways normally controlling the decision to divide, thereby resulting
in a neoplastic cell growth (4). In other words, a critical “driver mutation” can put the cell on
“autopilot.” From the viewpoint of the immune system, Burnet’s “Clonal Selection Theory,” derives
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from the observation that antigen-reactive clones of immune
cells are selected by antigen, but subsequent to selection, each
clone undergoes a proliferative clonal expansion (5). It is this
clonal proliferative expansion that is determined by the molec-
ular parameters discovered in this series of experiments focused
on IL-2 and T cells. Accordingly, the regulatory cells and other
cytokine molecules that influence the concentrations of the IL-
2 molecules, their receptors, and the molecules of their signaling
pathways ultimately determine the tempo, magnitude, and dura-
tion of immune responses. That is, internally derived hormones
and their receptors regulate the immune system, just as every other
bodily system is regulated, and immunity is not regulated solely by
environmental antigens fromwithout, a previous central dogma of
immunology.
For immunologists, it is especially noteworthy that the lym-
phocyte antigen receptors function in an identical fashion to
convert TCR signals to a digital control of cytokine gene
expression (6–10).
These findings and considerations, led me to propose “The
Quantal Theory of Immunity” (11–14). Thus, the immune system
is regulated at the systemic (population) level by the number of
clones responding and the extent of the proliferative expansion
of each clone as originally stated by Burnet. However, at the
level of individual cells, participation in an immune response
is regulated in a quantal (all-or-none) fashion, and this quantal
decision is determined by the absolute number of intermolecular
interactions, which the cells somehow “count.” Once the cru-
cial number has been surpassed, the cell responds in a quantal
fashion. It goes without mentioning that all of the molecules
and cells that participate in an immune response obey identical
principles.
Acknowledgments
The author is grateful for the continued support of the Belfer
Foundation.
References
1. Cantrell DA, Smith KA. The interleukin-2 T-cell system: a new cell growth
model. Science (1984) 224:1312–6. doi:10.1126/science.6427923
2. Smith KA, Favata MF, Oroszlan S. Production and characterization of mono-
clonal antibodies to human interleukin 2: strategy and tactics. J Immunol (1983)
131:1808–15.
3. Robb RJ, Munck A, Smith KA. T cell growth factor receptors: quantitation,
specificity, and biological relevance. J Exp Med (1981) 154:1455–74. doi:10.
1084/jem.154.5.1455
4. Smith KA, Griffin JD. Following the cytokine signaling pathway to leukemoge-
nesis: a chronology. J Clin Invest (2008) 118:3564–73. doi:10.1172/JCI35819
5. Burnet FM. A modification of Jerne’s theory of antibody production using the
concept of clonal selection. Aust J Sci (1957) 20:67–77.
6. Chiodetti L, Barber D, Schwartz R. Biallelic expression of the IL-2 locus under
optimal stimulation conditions. Eur J Immunol (2000) 30:2157–63. doi:10.1002/
1521-4141(2000)30:18<2157::AID-IMMU2157>3.0.CO;2-G
7. Podtschaske M, Benary U, Zwinger S, Hofer T, Radbruch A, Baumgrass R. Dig-
ital NFATc2 activation per cell transforms graded T cell receptor activation into
an all-or-none IL2 expression. PLoS One (2007) 2:e935. doi:10.1371/journal.
pone.0000935
8. Feinerman O, Jentsch G, Sneddon M, Emonet T, Smith K, Altan-Bonnet G.
Single-cell quantification of IL-2 dynamics in effector and regulatory T cells
reveals critical plasticity in immune responses. Mol Syst Biol (2010) 6:437.
doi:10.1038/msb.2010.90
9. Huang J, Brameshuber M, Zeng X, Xie J, Li Q, Chien Y, et al. A sin-
gle peptide-major histocompatibility complex ligand triggers digital cytokine
secretion in CD4 T cells. Immunity (2013) 39:846–57. doi:10.1016/j.immuni.
2013.08.036
10. Tkach K, Barik D, Viosinne G, Malandro N, Hathorn M, Cotari J, et al. T
cells translate individual, quantal activation into collective, analog cytokine
responses via time-integrated feedbacks. ELife (2014) 3:e01944. doi:10.7554/
eLife.01944
11. Smith K. The quantal theory of how the immune system discriminates between
“self and non-self ”.Med Immunol (2004) 3:3. doi:10.1186/1476-9433-3-3
12. Smith K. The quantal theory of immunity.Cell Res (2006) 16:11–9. doi:10.1038/
sj.cr.7310003
13. Smith K. The Quantal Theory of Immunity: The Molecular Basis of Autoimmu-
nity and Leukemia. Singapore: World Scientific Publishing Co. Pte. Ltd (2010).
243 p.
14. Smith K, Popmihajlov Z. The quantal theory of immunity and the interleukin-
2-dependent negative feedback regulation of the immune response. Immunol
Rev (2008) 224:124–40. doi:10.1111/j.1600-065X.2008.00654.x
Conflict of Interest Statement: The author declares that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Copyright © 2015 Smith. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordancewith
accepted academic practice. No use, distribution or reproduction is permitted which
does not comply with these terms.
Frontiers in Immunology | www.frontiersin.org August 2015 | Volume 6 | Article 4142
